Table 1 Main clinical and epidemiologic characteristics of individuals of this study
Characteristics | HIC (n = 21) | ART-suppressed (n = 10) | HIV-1 negative (n = 8) | |
|---|---|---|---|---|
EC (n = 13) | VC (n = 8) | |||
 Sex, no. (%) | ||||
  Female | 10 (77) | 3 (38) | 4 (50) | 6 (60) |
  Male | 3 (23) | 5 (62) | 4 (50) | 4 (40) |
  Age (years)ab | 45 (39–60) | 44 (39–47) | 47 (38–53) | 47 (36–51) |
 Study point | ||||
  Time since HIV-1 diagnosis (years)b | 9 (5.5–15) | 12.5 (7–16) | NA | – |
  CD4+ T cell (cells/μl)b | 1027 (834–1255) | 664 (563–1228) | 889 (678–1097) | 1043 (784–1581) |
  Plasma HIV RNA (copies/ml)b | < 50 | 641 (327–915) | < 40 | – |
  CD4/CD8 ratiob | 1.33 (1.24–1.61) | 0.91 (0.67–1.23) | 1.06 (0.73–1.5) | 1.69 (1.62–2.00) |